The first large-scale placebo-controlled clinical trial to determine the effects of Rapamycin on human longevity.
- 243% Funded
- $182,838 Funded
A company providing supplements and treatments believed to increase longevity based on the data from animal and human studies. They also conduct trials and research of their own and include a collection of longevity experts, doctors, and scholars.